Skip to Main Content

Author Details

Sebastian M Armasu
Division of Clinical Trials and Biostatistics, Mayo Clinic
2009
57
24
PMIDPaper TitleJournal TitlePublished Year
36790339Methylation Signature Implicated in Immuno-Suppressive Activities in Tubo-Ovarian High-Grade Serous Carcinoma.Cancer Epidemiol Biomarkers Prev2023
34782936MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.Virchows Arch2022
35816189Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes.Clin Cancer Res2022
36160147Computational tumor stroma reaction evaluation led to novel prognosis-associated fibrosis and molecular signature discoveries in high-grade serous ovarian carcinoma.Front Med (Lausanne)2022
36154123Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors.Circulation2022
35102242Identification of sex-specific genetic associations in response to opioid analgesics in a White, non-Hispanic cohort from Southeast Minnesota.Pharmacogenomics J2022
35331649Implementation of preemptive DNA sequence-based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study.Genet Med2022
34697060DNA Methylation Profiles of Ovarian Clear Cell Carcinoma.Cancer Epidemiol Biomarkers Prev2022
34162658Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2021
32125938Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.J Clin Oncol2020
33371009Expert artificial intelligence-based natural language processing characterises childhood asthma.BMJ Open Respir Res2020
30576442Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer.Hum Mol Genet2019
31279243Genome-wide DNA methylomic differences between dorsolateral prefrontal and temporal pole cortices of bipolar disorder.J Psychiatr Res2019
31420334Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.Blood2019
29594131A Genome-Wide Search for Bipolar Disorder Risk Loci Modified by Mitochondrial Genome Variation.Mol Neuropsychiatry2018
30062862Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.J Pathol Clin Res2018
29434467Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer.Cancer Inform2018
29036934Identification of Genetic Interaction with Risk Factors Using a Time-To-Event Model.Int J Environ Res Public Health2017
28280090Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes.Clin Cancer Res2017
28445597Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.J Thromb Haemost2017
28203683Identification of unique venous thromboembolism-susceptibility variants in African-Americans.Thromb Haemost2017
27545685Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease.Parkinsonism Relat Disord2016
27732966HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.Oncotarget2016
27449892Assessing health disparities in children using a modified housing-related socioeconomic status measure: a cross-sectional study.BMJ Open2016
27253175Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer.Br J Cancer2016
25991289Using EHR-Linked Biobank Data to Study Metformin Pharmacogenomics.Stud Health Technol Inform2015
26306225Leveraging an Electronic Health Record-Linked Biorepository to Generate a Metformin Pharmacogenomics Hypothesis.AMIA Jt Summits Transl Sci Proc2015
26343387A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease.Nat Genet2015
24479488Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer.BMC Med Genomics2014
25414722Controlling for population structure and genotyping platform bias in the eMERGE multi-institutional biobank linked to electronic health records.Front Genet2014
25412286Lack of replication of the GRIN2A-by-coffee interaction in Parkinson disease.PLoS Genet2014
24774302Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome.BMC Med Genomics2014
24853948Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer.Genet Epidemiol2014
24578302Alpha-synuclein repeat variants and survival in Parkinson's disease.Mov Disord2014
24656894Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?Parkinsonism Relat Disord2014
24728075Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer.Cancer Res2014
23571109Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel.Hum Mol Genet2013
23650146A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.Genet Epidemiol2013
23382860Inherited variants in regulatory T cell genes and outcome of ovarian cancer.PLoS One2013
23535731Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.Nat Genet2013
23535730GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer.Nat Genet2013
23535648Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.Nat Commun2013
23535649Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.Nat Commun2013
23507417Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.Parkinsonism Relat Disord2013
22253297Common variation in Nemo-like kinase is associated with risk of ovarian cancer.Cancer Epidemiol Biomarkers Prev2012
22532574Identification of a novel percent mammographic density locus at 12q24.Hum Mol Genet2012
22672568A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.J Thromb Haemost2012
22561516Detectable clonal mosaicism from birth to old age and its relationship to cancer.Nat Genet2012
22658654Genomic determinants of motor and cognitive outcomes in Parkinson's disease.Parkinsonism Relat Disord2012
21463476Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism.J Thromb Haemost2011
  • 1 - 50 of 57

Recommended Authors

Eric R Gamazon
Vanderbilt University Medical Center
Career Start Year 2009
Number of shared co-authors 47
Daryl Waggott
Ontario Institute for Cancer Research
Career Start Year 2009
Number of shared co-authors 33
Mitchell J Machiela
National Cancer Institute
Career Start Year 2008
Number of shared co-authors 61
Xiangjun Xiao
Institute for Clinical and Translational Research, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 56
Jianxin Shi
National Cancer Institute, 9609 Medical Center Drive
Career Start Year 2007
Number of shared co-authors 70
Zhaoming Wang
St Jude Children's Research Hospital
Career Start Year 2007
Number of shared co-authors 128
Younghun Han
Institute for Clinical and Translational Research, Baylor College of Medicine
Career Start Year 2007
Number of shared co-authors 73
William S Bush
Cleveland Institute for Computational Biology, Case Western Reserve University
Career Start Year 2006
Number of shared co-authors 54
Ian B Stanaway
Kidney Research Institute and Division of Nephrology, University of Washington
Career Start Year 2006
Number of shared co-authors 30
Laurie Burdett
National Cancer Institute, Frederick National Laboratory for Cancer Research
Career Start Year 2005
Number of shared co-authors 35
David W Craig
University of Southern California
Career Start Year 2004
Number of shared co-authors 14
Sarah S Murray
University of California San Diego Health System
Career Start Year 2004
Number of shared co-authors 47
Todd L Edwards
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 140
Scott J Hebbring
Marshfield Clinic Research Institute
Career Start Year 2003
Number of shared co-authors 41
Alison A Motsinger-Reif
National Institute of Environmental Health Sciences
Career Start Year 2002
Number of shared co-authors 13
Joel A Mefford
University of California los angeles
Career Start Year 2001
Number of shared co-authors 2
Stacey Gabriel
Broad Institute of MIT and Harvard
Career Start Year 2001
Number of shared co-authors 76
Paul Scheet
University of Texas M.D. Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 48
Andrew D Skol
The University of Chicago
Career Start Year 2001
Number of shared co-authors 17
Chao Xing
University of Texas Southwestern Medical Center
Career Start Year 1999
Number of shared co-authors 10
Yi-Ju Li
Duke University School of Medicine
Career Start Year 1998
Number of shared co-authors 7
Mathieu Lemire
The Hospital for Sick Children
Career Start Year 1997
Number of shared co-authors 32
Shannon K McDonnell
Mayo Clinic
Career Start Year 1996
Number of shared co-authors 73
Unnur Thorsteinsdottir
University of Iceland
Career Start Year 1995
Number of shared co-authors 90
Carolyn M Hutter
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 32
John S Witte
Stanford University School of Medicine
Career Start Year 1994
Number of shared co-authors 67
Matthew L Freedman
Dana-Farber Cancer Institute
Career Start Year 1993
Number of shared co-authors 97
Meredith Yeager
Frederick National Laboratory for Cancer Research
Career Start Year 1993
Number of shared co-authors 60
Yudi Pawitan
Karolinska Institute
Career Start Year 1988
Number of shared co-authors 23
Daniel J Schaid
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 112

Collaborators

Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 29
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 20
Melissa C Larson
Mayo Clinic
Co-authored papers 17
Stacey J Winham
Mayo Clinic
Co-authored papers 13
Chen Wang
Center for Individualized Medicine, Mayo Clinic
Co-authored papers 13
Joellen M Schildkraut
Rollins School of Public Health, Emory University
Co-authored papers 12
Mariza de Andrade
Mayo Clinic
Co-authored papers 12
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 10
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 10
Joanna M Biernacka
Mayo Clinic
Co-authored papers 10
Gottfried E Konecny
David Geffen School of Medicine at University of California Los Angeles
Co-authored papers 9
Mine S Cicek
Mayo Clinic
Co-authored papers 9
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 9
Andrew Berchuck
Duke School of Medicine
Co-authored papers 9
John A Heit
Mayo Clinic
Co-authored papers 9
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 9
Peter A Fasching
Otto-Friedrich-University Bamberg
Co-authored papers 8
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 8
Boris Winterhoff
University of Minnesota
Co-authored papers 8
Janet E Olson
Mayo Clinic
Co-authored papers 7
Bryan M McCauley
Division of Clinical Trials and Biostatistics, Mayo Clinic
Co-authored papers 7
Diether Lambrechts
Co-authored papers 7
Fergus J Couch
Mayo Clinic
Co-authored papers 7
Andreas du Bois
Co-authored papers 6
Montserrat Garcia-Closas
National Cancer Institute
Co-authored papers 6
Tanja Pejovic
Oregon Health & Science University
Co-authored papers 6
Jonathan Tyrer
Co-authored papers 6
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 6
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 6
Marc T Goodman
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 6
Release 1.2